VCM
BEAT

Vigilant Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Vigilant Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-298
Closed -$5K – 395
2016
Q2 		$5K Buy
+298
New +$4.38K ﹤0.01% 325

Other funds holding BEAT

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vigilant Capital Management's BEAT Position: Q3 2016 in Review

Vigilant Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2016, closing a stake of 298 shares — an estimated $5K sold.

Vigilant Capital Management first reported a position in BEAT in Q2 2016 and held it in 1 quarter. The position peaked at $5K in Q2 2016. 167 funds tracked by Wall St. Rank hold BEAT as of Q3 2016.

  • Vigilant Capital Management reported no remaining BioTelemetry, Inc. position as of Q3 2016 after selling out during the quarter.
  • Vigilant Capital Management sold 298 BioTelemetry, Inc. shares in Q3 2016, an estimated $5K.
  • Vigilant Capital Management first reported a position in BioTelemetry, Inc. in Q2 2016 and held it in 1 quarter.
  • Vigilant Capital Management's BioTelemetry, Inc. position peaked at $5K in Q2 2016.
  • 167 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2016.

Based on Vigilant Capital Management's 13F filing for Q3 2016, filed 14 Oct 2016.